| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 710895 | 3-[(1H-Indol-3-ylethyl)amino]-2-(3-isopropoxyphenyl)-2H-pyrido[4,3-e]-1,2,4,-thiadiazine 1,1-dioxide | 0.0435808621943462 | 0.28554578 |
| NSC 716032 | Null | 0.0435808621943462 | 0.35670851 |
| NSC 71669 | Null | 0.0435808621943462 | 0.16842419 |
| NSC 722867 | Null | 0.0435808621943462 | 0.25049777 |
| NSC 723548 | Null | 0.0435808621943462 | 0.38053918 |
| NSC 723732 | 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one | 0.0435808621943462 | 0.38658643 |
| NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.0435808621943462 | 0.11343481 |
| NSC 728038 | 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline | 0.0435808621943462 | 0.38751605 |
| NSC 737757 | 2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole | 0.0435808621943462 | 0.29359388 |
| NSC 740 | Methotrexate | 0.0435808621943462 | 0.32241684 |